Insulin glulisine Subcutaneous and Polatuzumab Vedotin-piiq
Determining the interaction of Insulin glulisine Subcutaneous and Polatuzumab Vedotin-piiq and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glulisine
Brand name: Apidra, Apidra OptiClik Cartridge, Apidra SoloStar Pen
Synonyms: Insulin glulisine, Insulin Glulisine
Generic Name: polatuzumab vedotin
Brand name: Polivy
Synonyms: Polatuzumab vedotin, Polatuzumab Vedotin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glulisine Subcutaneous-Polio vaccine, inactivated
- Insulin glulisine Subcutaneous-Poliovirus Vaccine (Inactivated)
- Insulin glulisine Subcutaneous-Poliovirus vaccine, inactivated Injection
- Insulin glulisine Subcutaneous-Polivy
- Insulin glulisine Subcutaneous-Polmon
- Insulin glulisine Subcutaneous-Polocaine
- Polatuzumab Vedotin-piiq-Insulin human inhaled Inhalation
- Polatuzumab Vedotin-piiq-Insulin human regular Injection
- Polatuzumab Vedotin-piiq-Insulin inhalation
- Polatuzumab Vedotin-piiq-Insulin isophane
- Polatuzumab Vedotin-piiq-Insulin isophane and insulin regular
- Polatuzumab Vedotin-piiq-Insulin lispro